Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It focuses on the discovery, development and commercialization of innovative treatments for severe, rare muscle disorders for which there is significant unmet medical need. Its platform utilizes custom-built throughput and translatable systems that measure integrated muscle function in whole organ extracts to identify small molecule precision medicines regulating key proteins in muscle tissue, initially focused on addressing rare neuromuscular and cardiac diseases. The company was founded by Badreddin Edris, Alan Russel and Peter A. Thompson in 2017 and is headquartered in Boulder, CO.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
110
Frequently Asked Questions
What is Market Cap of Edgewise Therapeutics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Edgewise Therapeutics Inc market cap is $1.69B.
What is the 52-week high for Edgewise Therapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Edgewise Therapeutics Inc 52 week high is $38.12 as of September 28, 2025.
What is the 52-week low for Edgewise Therapeutics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Edgewise Therapeutics Inc 52 week low is $10.60 as of September 28, 2025.
What is Edgewise Therapeutics Inc stock price today?
Edgewise Therapeutics Inc stock price today is $16.05.
What was Edgewise Therapeutics Inc stock price yesterday?
Edgewise Therapeutics Inc stock price yesterday was $14.89.
What is the PE ratio of Edgewise Therapeutics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Edgewise Therapeutics Inc’s P/E ratio is -10.32.
What is the Price-to-Book ratio of Edgewise Therapeutics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Edgewise Therapeutics Inc P/B ratio is 2.8702.
What is the 50-day moving average of Edgewise Therapeutics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Edgewise Therapeutics Inc 50-day moving average is $14.30.
How many employess does Edgewise Therapeutics Inc has?
